TRAVELING THE WORLD, WRITING WHAT THE PEOPLE NEED TO KNOW.
TRAVELING THE WORLD, WRITING WHAT THE PEOPLE NEED TO KNOW.
Though Republican lawmakers have painted this moment in Internet history as ‘doomsday,’ and rallied a last ditch-effort to block it, at midnight on Saturday the U.S. government will cede control of the web’s core naming directory to a multi-stakeholder nonprofit. The Internet Corporation for Assigned Names and Numbers (ICANN), a California-based group of international stakeholders Read More…
As the Bank of Japan continues its de facto nationalisation of the Japanese economy, things do not look good for the Land of the__ Setting Sun. But as Japan-based economic analyst Marc Abela explains, the coming crisis may be our only opportunity for a real reset.
Whatever the result is of this year’s presidential election, fundamental issues broiling behind the scenes will no doubt prove the virtual powerlessness of the POTUS to bring about positive developments for the people of this nation and of the world. The deep state machinery that controls our national destiny is much more powerful than the titular Read More…
Berlin, Germany – The most prominent bank in Germany is at risk of failure, with potentially profound effects for the EU, the United States and likely the rest of the world. Deutsche Bank shares have fallen sharply on the news that German Chancellor Angela Merkel won’t bail-out the struggling bank, with shares falling by as Read More…
This is a preview to the Era of Wisdom documentary “Toddlers on Adderall: History of “Big Pharma” and the Major Players,” to be released December 28, 2016. Written and directed by Cassius Kamarampi, narrated by Josh Mur. Music by Cassius Kamarampi. (Link to image credits and sources) Transcript (video below): In our society, we often Read More…
The biotechnology giant Monsanto has now partnered with the Broad Institute to develop seeds using genetic or genome editing technology. On Thursday, Monsanto announced a new partnership with the Broad Institute, a project of MIT and Harvard that focuses on a biomedical and genomic research. The new partnership grants Monsanto non-exclusive licensing for agriculture applications of CRISPR-Cas Read More…